You are required to be logged in to access the full website
Click here if you have forgotten your username or password
12 October 2026 - Taiwan and US-based biopharmaceutical company Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576) said on Monday that its partner Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), part of Changchun High-Tech Industries (Group) Co....
12 October 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Monday announced positive topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ101, a radiopharmaceutical therapy developed by its...
12 October 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Monday announced topline results from its Phase 3 ALOFT-IPF trial, which met its primary endpoint in evaluating admilparant in adults with idiopathic pulmonary fibrosis (I...
12 October 2026 - Swedish biopharmaceutical company Camurus AB (STO: CAMX) on Monday said it has received a Notice of Compliance from Health Canada for Oczyesa XR, a long-acting subcutaneous octreotide depot for adults with acromegaly who have respon...
12 October 2026 - ABL Texcell Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, said on Monday that it has acquired IntegraGen's assets and business operations following a ruling by the Evry Commercial Court on 9 October ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe